Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,232 | -62,846 | -77,959 | -39,329 | -145,231 |
| Depreciation Amortization | -2,311 | -2,577 | -2,057 | -1,061 | -7,916 |
| Accounts receivable | 6,915 | -34,920 | 19,347 | 22,881 | -33,914 |
| Other Working Capital | -80,725 | -100,625 | -27,004 | 2,459 | -66,325 |
| Other Operating Activity | 109,050 | 122,668 | 36,729 | 4,350 | 118,049 |
| Operating Cash Flow | $19,697 | $-78,300 | $-50,944 | $-10,700 | $-135,337 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -87 | -86 | -74 | -35 | -358 |
| Purchase Of Investment | -196,411 | -196,411 | -176,755 | -122,547 | -380,376 |
| Sale Of Investment | 424,530 | 351,029 | 228,079 | 137,429 | 476,132 |
| Investing Cash Flow | $228,032 | $154,532 | $51,250 | $14,847 | $95,398 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,261 | 2,049 | 1,713 | 290 | 100,842 |
| Common Stock Repurchased | -68,626 | -65,242 | -55,522 | -4,424 | -456 |
| Other Financing Activity | -78,248 | -26,286 | -25,279 | -24,456 | 26,668 |
| Financing Cash Flow | $-132,613 | $-89,479 | $-79,088 | $-28,590 | $127,054 |
| Beginning Cash Position | 123,080 | 123,080 | 123,080 | 123,080 | 35,965 |
| End Cash Position | 238,196 | 109,833 | 44,298 | 98,637 | 123,080 |
| Net Cash Flow | $115,116 | $-13,247 | $-78,782 | $-24,443 | $87,115 |
| Free Cash Flow | |||||
| Operating Cash Flow | 19,697 | -78,300 | -50,944 | -10,700 | -135,337 |
| Capital Expenditure | -87 | -86 | -74 | N/A | -358 |
| Free Cash Flow | 19,610 | -78,386 | -51,018 | -10,700 | -135,695 |